Pharmaceutical and Energy-Based Management of Sexual Problems in Women.

Cognitive sexual arousal Electric stimulation therapy Female sexual dysfunction Genital sexual arousal Hypoactive sexual desire Laser therapy Medicalization Radiofrequency therapy

Journal

The Urologic clinics of North America
ISSN: 1558-318X
Titre abrégé: Urol Clin North Am
Pays: United States
ID NLM: 0423221

Informations de publication

Date de publication:
Nov 2021
Historique:
entrez: 4 10 2021
pubmed: 5 10 2021
medline: 28 10 2021
Statut: ppublish

Résumé

This article summarizes and critiques the evidence for use of available pharmacotherapies (vasoactive, psychoactive, and hormonal medications) and energy-based therapies (laser, radiofrequency, shockwave, and neurostimulation) for treatment of female sexual dysfunction. The enthusiasm with which energy-based treatments for sexual dysfunction have been adopted is disproportionate to the amount of data currently available to support their clinical use. Pharmacotherapy for female sexual dysfunction has considerably more research evidence to justify its use. Patients must be empowered to make an informed, autonomous determination as to whether the risk/reward ratio favors the use of pharmacotherapy, energy-based therapy, or some other treatment intervention.

Identifiants

pubmed: 34602169
pii: S0094-0143(21)01856-5
doi: 10.1016/j.ucl.2021.06.006
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

473-486

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Alexandra Siegal (A)

Department of Urology, Icahn School of Medicine at Mount Sinai, 1468 Madison Avenue, 6th Floor, New York, NY 10029, USA.

Barbara M Chubak (BM)

Department of Urology, Icahn School of Medicine at Mount Sinai, 10 Union Square #3A, New York, NY 10003, USA. Electronic address: Barbara.Chubak@mountsinai.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH